Skip to main content
. 2019 Jun;11(6):2251–2266. doi: 10.21037/jtd.2019.06.24

Table 2. The association of the clinicopathological characteristics.

Factors (n) 0–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79 80–84 85+ P
Sex <0.01
   Female 1,718 2,862 5,173 7,299 9,787 12,063 11,775 10,631 7,385 3,762
   Male 1,416 2,691 5,745 9,231 12,219 14,247 12,986 10,820 6,969 3,140
Race <0.01
   White 2,235 4,072 8,051 12,536 17,337 21,382 20,465 17,907 12,208 5,777
   Black 465 957 1,962 2,706 3,006 3,039 2,372 1,840 953 478
   Others 419 508 877 1,246 1,618 1,840 1,863 1,668 1,164 634
   Unknown 15 16 28 42 45 49 61 36 29 13
Histology <0.01
   Adenocarcinoma 2,633 4,363 8,180 11,743 14,841 16,955 15,505 13,276 9,041 4,548
   Squamous 501 1,190 2,738 4,787 7,165 9,355 9,256 8,175 5,313 2,354
Surgery <0.01
   No 2,147 3,801 7,441 10,958 14,188 16,429 15,941 14,433 10,745 5,974
   Yes 987 1,752 3,477 5,572 7,818 9,881 8,820 7,018 3,609 928
Radiation <0.01
   No 1,586 2,847 5,590 8,785 12,533 15,595 15,114 13,533 9,075 2,416
   Yes 1,490 2,624 5,168 7,483 9,159 10,301 9,252 7,648 5,070 4,396
   Unknown 58 82 160 262 314 414 395 270 209 90
LNM stage <0.01
   Ia 282 555 1,265 2,082 3,279 4,272 4,088 3,330 820 820
   Ib 254 488 948 1,626 2,550 3,403 3,291 3,119 1,009 1,009
   IIa 44 81 130 245 304 391 364 283 48 48
   IIb 105 259 479 772 1,008 1,353 1,165 1,034 276 276
   IIIa 255 476 1,052 1,601 2,128 2,654 2,465 2,098 592 592
   IIIb 484 867 1,738 2,663 3,504 3,989 3,998 3,626 1,553 1,553
   IV 1,684 2,764 5,200 7,350 9,003 9,923 9,050 7,625 2,437 2,437
   Unknown 26 63 106 191 230 325 340 336 167 167
N stage <0.01
   N0 1,009 1,924 3,873 6,123 9,082 11,685 11,466 10,271 6,941 3,388
   N1 289 584 1,050 1,685 2,192 2,605 2,284 1,980 1,264 527
   N2 1,172 2,012 4,045 6,023 7,514 8,608 7,946 6,708 4,388 2,091
   N3 546 888 1,649 2,251 2,657 2,714 2,366 1,789 1,164 510
   Unknown 118 145 301 448 561 698 699 703 597 386
Lymph node metastasis <0.01
   No 1,009 1,924 3,873 6,123 9,082 11,685 11,466 10,271 6,941 3,388
   Yes 2,007 3,484 6,744 9,959 12,363 13,927 12,596 10,477 6,816 3,128
   Unknown 118 145 301 448 561 698 699 703 597 386
Tumor location <0.01
   Left 1,854 3,216 6,457 9,601 12,652 15,123 14,116 12,236 8,148 3,841
   Right 1,150 2,175 4,204 6,562 8,935 10,694 10,222 8,829 5,901 2,858
   Paired sites 119 147 234 335 386 438 380 346 273 185
   Unknown 11 15 23 32 33 55 43 40 32 18
T stage <0.01
   T1 587 1,112 2,312 3,641 5,187 6,620 6,270 5,117 3,122 1,258
   T2 862 1,663 3,421 5,308 7,216 9,032 8,370 7,564 5,007 2,316
   T3 201 368 766 1,197 1,454 1,769 1,606 1,338 872 375
   T4 1,484 2,410 4,419 6,384 8,149 8,889 8,515 7,432 5,353 2,953
M stage <0.01
   M0 1,426 2,733 5,626 9,021 12,812 16,131 15,447 13,589 8,914 4,336
   M1 1,684 2,764 5,200 7,350 9,003 9,923 9,050 7,625 5,235 2,437
   Unknown 24 56 92 159 191 256 264 237 205 129
Year of diagnosis <0.01
   2004 337 512 877 1,344 1,777 2,069 2,025 1,818 1,063 426
   2005 318 524 873 1,355 1,767 2,011 1,982 1,768 1,142 437
   2006 332 582 1,010 1,460 1,877 2,199 2,168 1,855 1,205 542
   2007 305 587 966 1,491 2,058 2,430 2,277 1,979 1,233 565
   2008 298 583 1,096 1,566 2,124 2,602 2,310 2,056 1,365 653
   2009 309 609 1,142 1,673 2,319 2,622 2,537 2,205 1,501 728
   2010 302 573 1,272 1,842 2,357 2,932 2,661 2,374 1,661 822
   2011 339 569 1,298 1,852 2,569 3,046 2,784 2,383 1,725 821
   2012 303 537 1,226 2,007 2,589 3,237 2,961 2,557 1,794 932
   2013 291 477 1,158 1,940 2,569 3,162 3,056 2,456 1,665 976